Sun Pharma Advanced Research Share Price

Sun Pharma Advanced Research Share Price

NSE: SPARC
|
Diversified
|
S Cap
₹ 193.92
+₹0.76 (0.39%)
1D
Last updated 18 Sep, 2026, 15:51 IST

Sun Pharma Advanced Research Share Price Today

As of 19 Sep 2026, Sun Pharma Advanced Research share price is ₹193.92. The stock opened at ₹193.16, compared to its previous close of ₹193.16. During today's trading session, Sun Pharma Advanced Research share price moved in the range of ₹192.39 to ₹198.60, with an average price of ₹195.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹108.00 and a high of ₹289.00. On the performance front, Sun Pharma Advanced Research share price has increased by 61.26% over the last six months and is up 34.79% on a year-on-year basis.

₹192.39
0.39% up today
₹198.60
1D LOW
1D HIGH

Sun Pharma Advanced Research Returns Calculator

Circuit
L
H
₹174.53
₹213.31
52-week
L
H
₹108.00
₹289.00

About Sun Pharma Advanced Research

Sun Pharma Advanced Research Share Price
ISIN
INE232I01014
Sector Market Cap
₹ 6,273.00 Cr

Sun Pharma Advanced Research Company Limited is an India-based clinical-stage biopharmaceutical company that focuses on developing therapeutics to improve standards of care for patients worldwide. The Company’s therapeutic focus is in the area of oncology, neurology and immunology. Its lead oncology programs include vodobatinib (SCO-088), a BCR-ABL targeting tyrosine kinase inhibitor for refractory chronic myelogenous leukemia, and an anti-MUC-1 antibody-drug conjugate (ADC) with the potential to treat multiple cancers. The Company’s other programs include Sezaby for the treatment of neonatal seizures, Vodobatinib for the treatment of neurodegenerative disorders (SCC-138), Vibozilimod for the treatment of autoimmune disorders (SCD-044), SCD-153 for the treatment of alopecia areata, SBO-154 for multiple cancer indications and SCO-155 for treatment of cancer. SBO-154 is an anti MUC1 ADC being developed for multiple tumor types expressing MUC1.

Sun Pharma Advanced Research Financial Highlights

  • Revenue: Sun Pharma Advanced Research reported revenue of ₹1,890.12 crore in FY26 vs ₹73.56 crore in FY25. It showed an increase of 2,469.49% on a yearly basis.
  • Operating Profit: Sun Pharma Advanced Research reported an operating profit of ₹1,553.01 crore in FY26 vs ₹342.78 crore in FY25. It showed an increase of 553.06% on a year-on-year basis.
  • Net Profit: Sun Pharma Advanced Research reported a net profit of ₹1,553.20 crore in FY26 vs ₹342.51 crore in FY25. It showed an increase of 553.48% on a yearly basis.

Sun Pharma Advanced Research Quarterly Result Highlights

  • Sun Pharma Advanced Research reported revenue of ₹63.58 crore in Jun 2026, compared with ₹1,855.02 crore in Mar 2026, representing a decrease of 96.57% on a quarter-on-quarter (QoQ) basis.
  • Sun Pharma Advanced Research reported an operating loss of ₹20.67 crore in Jun 2026, compared with ₹1,760.96 crore in Mar 2026, representing a decrease of 101.17% on a quarter-on-quarter (QoQ) basis.
  • Sun Pharma Advanced Research reported a loss of ₹20.78 crore in Jun 2026, compared with ₹1,761.34 crore in Mar 2026, reflecting a decrease of 101.18% on a QoQ basis.
  • The earnings per share (EPS) of Sun Pharma Advanced Research stood at ₹47.86 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
65.67%
FII
3.90%
Other DII
0.01%
Retail and other
30.33%
Mutual funds
0.08%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20252.04%
Mar 20262.04%
May 20262.47%
Jun 20263.90%
Mkt Cap Cr
6,297.34
P/E
3.97
P/B
4.70
ROE
116.01%
D/E
0.42
ROCE
80.89%
Div. Yield
0.00%
EPS(TTM)
47.83
Turnover
0.03
EV/EBITDA
4.19
Net Margin
82.60%
Op. Margin
84.95%
ROA
72.98%
Quick Ratio
2.46
Curr. Ratio
9.35
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
SPARC outperforming most market indices
Step 3 of 5
Valuation
Fairly Valued
SPARC appears to be fairly valued compared to its peers
Step 3 of 5
Earnings
Neutral
SPARC earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,40,398.0036.355.2713.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,664.0085.0214.8415.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,82,738.0084.7621.7325.49%1.6913.85%222.760.70%0.4958.70
Zydus Lifesciences1,15,012.0025.044.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,794.0033.023.2211.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,05,645.0096.8919.9316.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories97,749.4030.712.5711.07%0.1812.54%377.950.68%0.4138.68
Aurobindo Pharma99,828.1026.902.639.25%0.1911.76%394.820.23%0.3841.58
Lupin98,069.8017.674.3723.76%0.0424.88%659.000.84%0.57129.18
Mankind Pharma95,743.9046.305.8711.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Sun Pharma Advanced Research Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,879.17₹71.77₹75.55₹238.78
Other Income₹10.95₹1.79₹29.47₹10.88
Total Revenue₹1,890.12₹73.56₹105.01₹249.66
Total Expenses₹324.75₹416.34₹491.85₹472.24
Profit Before Tax₹1,553.01-₹342.78-₹386.83-₹222.58
Tax-₹0.19-₹0.27₹0.38₹0.00
Profit After Tax₹1,553.20-₹342.51-₹387.21-₹222.58
EPS - Basic₹47.86-₹10.55-₹11.93-₹7.82
EPS - Diluted₹47.86-₹10.55-₹11.93-₹7.82

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,553.01-₹342.78-₹386.83-₹222.58
Income before WC changes₹1,594.17-₹322.26-₹397.74-₹215.59
Change in Assets-₹1,850.30₹2.92-₹47.88₹5.40
Change in Liabilities-₹14.29-₹49.78₹20.54₹135.71
Change in WC-₹1,864.59-₹46.86-₹27.33₹141.11
Cash flow from Operations-₹238.78-₹360.29-₹429.19-₹69.12
Cash flow from Investing-₹23.50₹157.66₹391.53-₹548.28
Cash flow from Financing₹261.39₹199.26₹42.41₹616.76
Total Cash Flow-₹0.89-₹3.38₹4.74-₹0.64
Cash (Start of the year)₹1.96₹5.33₹0.58₹1.22
Cash (End of the year)₹1.16₹1.96₹5.33₹0.58

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹308.45₹309.34₹245.66₹375.16
Current Assets₹1,862.43₹26.20₹269.39₹454.96
Total Assets₹2,170.88₹335.53₹515.04₹830.13
Current Liabilities₹754.11₹374.24₹265.06₹178.95
Net Current Asset₹1,108.32-₹348.04₹4.33₹276.02
Non-Current Liabilities₹77.94₹178.24₹124.23₹138.41
Equity Capital₹1,338.83-₹216.95₹125.76₹512.78
Total Equity & Liabilities₹2,170.88₹335.53₹515.04₹830.13

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,879.17₹71.77₹75.55₹238.78
Other Income₹10.83₹1.79₹29.47₹10.88
Total Revenue₹1,890.00₹73.56₹105.01₹249.66
Total Expenses₹325.50₹418.78₹493.12₹472.24
Profit Before Tax₹1,552.13-₹345.22-₹388.11-₹222.58
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax₹1,552.13-₹345.22-₹388.11-₹222.58
EPS - Basic₹47.83-₹10.64-₹11.96-₹7.82
EPS - Diluted₹47.83-₹10.64-₹11.96-₹7.82

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,552.13-₹345.22-₹388.11-₹222.58
Income before WC changes₹1,593.27-₹326.40-₹399.44-₹215.59
Change in Assets-₹1,850.28-₹19.94-₹25.34₹5.40
Change in Liabilities-₹13.52-₹26.86-₹0.54₹135.71
Change in WC-₹1,863.80-₹46.80-₹25.88₹141.11
Cash flow from Operations-₹238.89-₹362.41-₹429.43-₹69.12
Cash flow from Investing-₹23.51₹157.66₹391.11-₹548.28
Cash flow from Financing₹261.53₹200.88₹42.80₹616.76
Total Cash Flow-₹0.87-₹3.87₹4.48-₹0.64
Cash (Start of the year)₹1.19₹5.06₹0.58₹1.22
Cash (End of the year)₹0.32₹1.19₹5.06₹0.58

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹306.61₹304.02₹239.93₹375.16
Current Assets₹1,861.38₹25.26₹246.41₹454.96
Total Assets₹2,167.99₹329.28₹486.33₹830.13
Current Liabilities₹756.83₹373.72₹243.89₹178.95
Net Current Asset₹1,104.55-₹348.46₹2.52₹276.02
Non-Current Liabilities₹77.58₹176.17₹117.59₹138.41
Equity Capital₹1,333.59-₹220.62₹124.86₹512.78
Total Equity & Liabilities₹2,167.99₹329.28₹486.33₹830.13
* All values are in INR Crore
Qty
Bid
754
193.92
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 754
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
44.23
Neutral
ATR (14)
8.24
Neutral
STOCH(9,6)
44.73
Neutral
STOCH RSI (14)
56.32
Neutral
ADX(9)
25.61
Bearish
UO(9)
37.65
Neutral
ROC(12)
-1.55
Bearish
WillR(14)
-55.27
Neutral
Period
Simple value
Exponential vaue
5D
191.34
192.89
10D
196.28
194.71
20D
197.22
197.6
50D
209.3
203.64
100D
207.87
197.9
Volume trend — traded volume by day
18 Sep6L
17 Sep8L
16 Sep6L
15 Sep6L
Average7L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Sun Pharma Advanced Research Share Price
Sun Pharma Advanced Research
Diversified
Add Stock
Add Another

Sun Pharma Advanced Research Share Price FAQs

Sun Pharma Advanced Research share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837